Platinum Industries Limited — Board Meeting, 12-02-2026: Outcome of Board Meeting
12-02-2026 | 05:21 pm
12-02-2026 | 05:21 pm
Platinum Industries' board approved consolidated financial results for Q3 & 9 months ending Dec 31, 2025. They also greenlit a new Pharma/Lifesciences subsidiary, 'Rivadu Lifesciences Private Limited,' with initial capital up to ₹0.25 Cr. #PLATIND
No comments yet. Be the first to comment!
